Related Experiment Video
Updated: Aug 6, 2026

08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Obesity and the pulmonologist
Archives of Disease in Childhood
|January 24, 2006
Summary
Obese children experience more respiratory issues, including breathlessness and obstructive sleep apnea, due to weight. Addressing nutritional obesity is key to preventing future respiratory problems in children.
Area of Science:
- Pediatric Pulmonology
- Obesity Medicine
- Respiratory Health
Background:
- Obesity is linked to increased respiratory symptoms in children.
- Respiratory pathology escalates with rising body weight.
- Mechanical effects of obesity impact respiratory system function.
Purpose of the Study:
- To investigate the relationship between childhood obesity and respiratory symptoms.
- To highlight the mechanical and physiological impacts of obesity on the pediatric respiratory system.
- To underscore the potential for preventable respiratory morbidity in obese children.
Main Methods:
- Review of existing literature on obesity and pediatric respiratory conditions.
- Analysis of the mechanical effects of excess weight on respiratory mechanics.
- Examination of the link between obesity and obstructive sleep apnea in children.
Main Results:
- Obese children exhibit higher rates of respiratory symptoms like breathlessness, wheeze, and cough.
- These symptoms are often mechanical and may not respond to traditional bronchodilator therapy.
- A significant proportion of obese children present with obstructive sleep apnea due to upper airway changes.
Conclusions:
- Childhood obesity significantly contributes to respiratory morbidity.
- Weight loss may be more effective than bronchodilators for certain respiratory symptoms in obese children.
- Urgent interventions are needed to mitigate the rising tide of obesity-related respiratory issues in pediatric populations.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

